About Us
Company Background
Core Values
Evolution and Sales
Manufacturing Facilities
Marketing Entities
PRODUCTS
OTC
NASOMOM
FOREVA
BRIZ
MOME-AIR
API
PRODUCTS
ETC
HEPATITIS B
RICOVIR
HEPATITIS C
MYHEP
LEDVIR
PrEP
RICOVIR-EM
ONCOLOGY
IMATINIB 100 MG
IMATINIB 400 MG
HERTRAZ 150 MG
HERTRAZ 440 MG
ERLONAT 100 MG
ERLONAT 150 MG
MEDICAL DEVICES
Products
News
Medical Information
Company Activities
Videos
RECRUITMENT
Enquiry
Contact
Hotline
: 0909 25 22 75
About Us
Company Background
Core Values
Evolution and Sales
Manufacturing Facilities
Marketing Entities
PRODUCTS
OTC
NASOMOM
FOREVA
BRIZ
MOME-AIR
API
PRODUCTS
ETC
HEPATITIS B
RICOVIR
HEPATITIS C
MYHEP
LEDVIR
PrEP
RICOVIR-EM
ONCOLOGY
IMATINIB 100 MG
IMATINIB 400 MG
HERTRAZ 150 MG
HERTRAZ 440 MG
ERLONAT 100 MG
ERLONAT 150 MG
MEDICAL DEVICES
Products
News
Medical Information
Company Activities
Videos
RECRUITMENT
Enquiry
Contact
“PROGRESS IN DIAGNOSIS AND TREATMENT OF CIRRHOSIS” – 27/12/2015
About Reliv
API
Company Activities
Contact
Core Values
Enquiry
Introduction
Manufacturing Facilities
Marketing Entities
MEDICAL REPRESENTATIVE
News
RECRUITMENT
Reliv Evolution and Sales
Reliv’s Activities
RELIV’S NEWS
Report on VTV1 – Treatment with Hepatitis C
RVK MEDITECH, MYANMAR
SCIENTIFIC CONFERENCE IN HAU GIANG PROVINCE – JUN 22 , 2016
SEMINAR OF HERTRAZ AT HA NOI ONCOLOGY HOSPITAL – JUL 12, 2016
SEMINAR OF HERTRAZ AT K3 HOSPITAL (Internal 2 Department) – JUL 13, 2016
LEDVIR